Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122103434 | 12210343 | 4 | F | 20151030 | 20160718 | 20160325 | 20160729 | EXP | ZA-ROCHE-1730260 | ROCHE | 39.55 | YR | F | Y | 60.00000 | KG | 20160730 | MD | ZA | ZA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122103434 | 12210343 | 1 | PS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 103705 | 625 | MG | SOLUTION FOR INFUSION | QD | |||||||
122103434 | 12210343 | 2 | SS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 103705 | 615 | MG | SOLUTION FOR INFUSION | QD | |||||||
122103434 | 12210343 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 940 | MG | QD | ||||||||
122103434 | 12210343 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 925 | MG | |||||||||
122103434 | 12210343 | 5 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 65 | MG | QD | ||||||||
122103434 | 12210343 | 6 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 60 | MG | QD | ||||||||
122103434 | 12210343 | 7 | SS | Vincristine | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 0 | 2 | MG | QD | ||||||||
122103434 | 12210343 | 8 | SS | Vincristine | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 0 | 1 | MG | QD | ||||||||
122103434 | 12210343 | 9 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 0 | 150 | MG | QD | ||||||||
122103434 | 12210343 | 10 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 0 | 150 | MG | QD | ||||||||
122103434 | 12210343 | 11 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | QD | ||||||||
122103434 | 12210343 | 12 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4MG TWICE A DAY FOR 3 DAYS | 0 | 4 | MG | BID | |||||||
122103434 | 12210343 | 13 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | QD | ||||||||
122103434 | 12210343 | 14 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4MG ORALLY TWICE A DAY FOR 3 DAYS | 0 | 4 | MG | BID | |||||||
122103434 | 12210343 | 15 | SS | SOLU-CORTEF | HYDROCORTISONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 0 | 300 | MG | QD | ||||||||
122103434 | 12210343 | 16 | SS | SOLU-CORTEF | HYDROCORTISONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 0 | 300 | MG | QD | ||||||||
122103434 | 12210343 | 17 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 60 | MG | QD | ||||||||
122103434 | 12210343 | 18 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 60MG ORALLY ONCE DAILY FOR 7 DAYS | 0 | 60 | MG | QD | |||||||
122103434 | 12210343 | 19 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25MG 3 TIMES A DAY FOR 24 HOURS | 0 | 25 | MG | TID | |||||||
122103434 | 12210343 | 20 | SS | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25MG 3 TIMES DAILY FOR 24 HOURS | 0 | 25 | MG | TID | |||||||
122103434 | 12210343 | 21 | SS | PANADO | ACETAMINOPHEN | 1 | Oral | 2 TABLETS 6 HOURLY X 24 HOURS | 0 | Q6H | |||||||||
122103434 | 12210343 | 22 | SS | PANADO | ACETAMINOPHEN | 1 | Oral | 2 TABLETS 6 HOURLY ORALLY FOR 24 HOURS | 0 | QID | |||||||||
122103434 | 12210343 | 23 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | QD | ||||||||
122103434 | 12210343 | 24 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | 300 | MG | QD | ||||||||
122103434 | 12210343 | 25 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | |||||||||||
122103434 | 12210343 | 26 | C | LANZOR | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
122103434 | 12210343 | 27 | C | RIFINAH | ISONIAZIDRIFAMPIN | 1 | Oral | 2 TABLETS DAILY | 0 | ||||||||||
122103434 | 12210343 | 28 | C | PYRIDOXINE | PYRIDOXINE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
122103434 | 12210343 | 29 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 0 | 200 | MG | BID | ||||||||
122103434 | 12210343 | 30 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 0 | 200 | MG | BID | ||||||||
122103434 | 12210343 | 31 | C | FOLATE | FOLATE SODIUM | 1 | Oral | 0 | 5 | MG | QD | ||||||||
122103434 | 12210343 | 32 | C | FOLATE | FOLATE SODIUM | 1 | Oral | 0 | 5 | MG | QD | ||||||||
122103434 | 12210343 | 33 | C | AZT | ZIDOVUDINE | 1 | Oral | 0 | 300 | MG | BID | ||||||||
122103434 | 12210343 | 34 | C | 3TC | LAMIVUDINE | 1 | Oral | 0 | 150 | MG | BID | ||||||||
122103434 | 12210343 | 35 | C | LOPINAVIR/RITONAVIR | LOPINAVIRRITONAVIR | 1 | Oral | 4 TABLETS TWICE A DAY | 0 | BID | |||||||||
122103434 | 12210343 | 36 | C | ALDARA | IMIQUIMOD | 1 | Unknown | APPLY TO WARTS THREE TIMES A WEEK | 0 | ||||||||||
122103434 | 12210343 | 37 | C | TRAMAL | TRAMADOL | 1 | Unknown | 0 | 50 | MG | BID | ||||||||
122103434 | 12210343 | 38 | C | ANUSOL CREAM (BISMUTH OXIDE/PERUVIAN BALSAM/ZINC OXIDE) | 2 | Unknown | APPLY WHEN NECESSARY TO HAEMORRHOIDS | 0 | |||||||||||
122103434 | 12210343 | 39 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 10ML 3 TIMES DAILY WHEN NECESSARY | 0 | 10 | ML | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122103434 | 12210343 | 1 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 3 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 5 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 7 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 9 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 11 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 15 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 17 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 19 | Diffuse large B-cell lymphoma |
122103434 | 12210343 | 21 | Diffuse large B-cell lymphoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122103434 | 12210343 | HO |
122103434 | 12210343 | LT |
122103434 | 12210343 | OT |
122103434 | 12210343 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122103434 | 12210343 | Anaemia | |
122103434 | 12210343 | Anogenital warts | |
122103434 | 12210343 | Blood sodium decreased | |
122103434 | 12210343 | Cardiopulmonary failure | |
122103434 | 12210343 | Clostridium difficile colitis | |
122103434 | 12210343 | Electrolyte imbalance | |
122103434 | 12210343 | Gastroenteritis | |
122103434 | 12210343 | Haemorrhoids | |
122103434 | 12210343 | Hyperkalaemia | |
122103434 | 12210343 | Hypocalcaemia | |
122103434 | 12210343 | Hyponatraemia | |
122103434 | 12210343 | Leukopenia | |
122103434 | 12210343 | Lymphopenia | |
122103434 | 12210343 | Neutropenia | |
122103434 | 12210343 | Neutrophilia | |
122103434 | 12210343 | Night sweats | |
122103434 | 12210343 | Pleural effusion | |
122103434 | 12210343 | Pneumonia | |
122103434 | 12210343 | Pyrexia | |
122103434 | 12210343 | Renal impairment | |
122103434 | 12210343 | Respiratory distress | |
122103434 | 12210343 | Sepsis | |
122103434 | 12210343 | Sinus tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122103434 | 12210343 | 1 | 20151020 | 20151020 | 0 | |
122103434 | 12210343 | 2 | 20151201 | 20151201 | 0 | |
122103434 | 12210343 | 3 | 20151020 | 20151020 | 0 | |
122103434 | 12210343 | 4 | 20151201 | 20151201 | 0 | |
122103434 | 12210343 | 5 | 20151020 | 20151020 | 0 | |
122103434 | 12210343 | 6 | 20151201 | 20151201 | 0 | |
122103434 | 12210343 | 7 | 20151020 | 20151020 | 0 | |
122103434 | 12210343 | 8 | 20151201 | 20151201 | 0 | |
122103434 | 12210343 | 9 | 20151020 | 20151020 | 0 | |
122103434 | 12210343 | 10 | 20151201 | 20151201 | 0 | |
122103434 | 12210343 | 11 | 20151020 | 0 | ||
122103434 | 12210343 | 13 | 20151201 | 0 | ||
122103434 | 12210343 | 14 | 20151201 | 0 | ||
122103434 | 12210343 | 15 | 20151020 | 20151020 | 0 | |
122103434 | 12210343 | 16 | 20151201 | 0 | ||
122103434 | 12210343 | 17 | 20151020 | 20151026 | 0 | |
122103434 | 12210343 | 18 | 20151201 | 0 | ||
122103434 | 12210343 | 19 | 20151020 | 0 | ||
122103434 | 12210343 | 20 | 20151201 | 0 | ||
122103434 | 12210343 | 21 | 20151020 | 0 | ||
122103434 | 12210343 | 22 | 20151201 | 0 | ||
122103434 | 12210343 | 23 | 20151020 | 0 | ||
122103434 | 12210343 | 24 | 20151201 | 0 | ||
122103434 | 12210343 | 25 | 20151211 | 0 | ||
122103434 | 12210343 | 26 | 20151020 | 0 | ||
122103434 | 12210343 | 27 | 20151020 | 0 | ||
122103434 | 12210343 | 28 | 20151020 | 0 | ||
122103434 | 12210343 | 29 | 20151020 | 0 | ||
122103434 | 12210343 | 30 | 20151201 | 0 | ||
122103434 | 12210343 | 31 | 20151020 | 0 | ||
122103434 | 12210343 | 32 | 20151201 | 0 | ||
122103434 | 12210343 | 33 | 20151020 | 0 | ||
122103434 | 12210343 | 34 | 20151020 | 0 | ||
122103434 | 12210343 | 35 | 20151020 | 0 | ||
122103434 | 12210343 | 36 | 20151201 | 0 | ||
122103434 | 12210343 | 37 | 20151201 | 20151214 | 0 | |
122103434 | 12210343 | 38 | 20151201 | 0 | ||
122103434 | 12210343 | 39 | 20151201 | 0 |